Ángel Martínez González, Manuella González Nunes, Noelia Pena Piñeiro, Maite Argibay Ulloa, Francisco Javier Fraile Amador, José Llópiz Castedo, Sandra Milena Jaimes Jaimes, Julia Rodríguez Pulian, Thalía Chantal Rodríguez Castiñeira, Joana Isabel Silva Sousa, Camila Eugenia Sieiro Peña, María Guadalupe González Valladares
{"title":"[减肥手术的长期有效性:10年随访后的体重和代谢结果]。","authors":"Ángel Martínez González, Manuella González Nunes, Noelia Pena Piñeiro, Maite Argibay Ulloa, Francisco Javier Fraile Amador, José Llópiz Castedo, Sandra Milena Jaimes Jaimes, Julia Rodríguez Pulian, Thalía Chantal Rodríguez Castiñeira, Joana Isabel Silva Sousa, Camila Eugenia Sieiro Peña, María Guadalupe González Valladares","doi":"10.20960/nh.05876","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>we evaluated the 10-year outcomes of bariatric surgery in a prospective cohort, focusing on weight loss and the evolution of comorbidities.</p><p><strong>Methods: </strong>this was an observational study involving 96 patients who underwent surgery between 2013 and 2024. We analyzed the percentage of excess weight loss (%EWL) and comorbidity remission. Of the patients, 78.1 % underwent gastric bypass (GB) and 19.8 % vertical sleeve gastrectomy (SG).</p><p><strong>Results: </strong>the %EWL peaked at 57.3 % at 2 years and remained at 43.3 % at 10 years. Preoperative diabetes and hypertension were independent predictors of reduced weight loss. GB showed significant superiority over SG in %EWL at both 5 and 10 years (p < 0.05). Remission rates were high for diabetes, hypertension, dyslipidemia, obstructive sleep apnea (OSA), and hepatic steatosis, with no significant differences between surgical techniques. Mechanical arthropathy did not improve significantly during follow-up (48.9 % vs 50.5 %; p = 0.88).</p><p><strong>Conclusions: </strong>bariatric surgery maintains clinically relevant weight loss at 10 years, with GB proving superior to SG in the long term. Comorbidities improve significantly, except for arthropathy, which persists despite weight loss.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Long-term effectiveness of bariatric surgery: weight and metabolic outcomes after 10 years of follow-up].\",\"authors\":\"Ángel Martínez González, Manuella González Nunes, Noelia Pena Piñeiro, Maite Argibay Ulloa, Francisco Javier Fraile Amador, José Llópiz Castedo, Sandra Milena Jaimes Jaimes, Julia Rodríguez Pulian, Thalía Chantal Rodríguez Castiñeira, Joana Isabel Silva Sousa, Camila Eugenia Sieiro Peña, María Guadalupe González Valladares\",\"doi\":\"10.20960/nh.05876\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>we evaluated the 10-year outcomes of bariatric surgery in a prospective cohort, focusing on weight loss and the evolution of comorbidities.</p><p><strong>Methods: </strong>this was an observational study involving 96 patients who underwent surgery between 2013 and 2024. We analyzed the percentage of excess weight loss (%EWL) and comorbidity remission. Of the patients, 78.1 % underwent gastric bypass (GB) and 19.8 % vertical sleeve gastrectomy (SG).</p><p><strong>Results: </strong>the %EWL peaked at 57.3 % at 2 years and remained at 43.3 % at 10 years. Preoperative diabetes and hypertension were independent predictors of reduced weight loss. GB showed significant superiority over SG in %EWL at both 5 and 10 years (p < 0.05). Remission rates were high for diabetes, hypertension, dyslipidemia, obstructive sleep apnea (OSA), and hepatic steatosis, with no significant differences between surgical techniques. Mechanical arthropathy did not improve significantly during follow-up (48.9 % vs 50.5 %; p = 0.88).</p><p><strong>Conclusions: </strong>bariatric surgery maintains clinically relevant weight loss at 10 years, with GB proving superior to SG in the long term. Comorbidities improve significantly, except for arthropathy, which persists despite weight loss.</p>\",\"PeriodicalId\":19385,\"journal\":{\"name\":\"Nutricion hospitalaria\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nutricion hospitalaria\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.20960/nh.05876\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BUSINESS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutricion hospitalaria","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20960/nh.05876","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BUSINESS","Score":null,"Total":0}
引用次数: 0
摘要
前言:我们在一个前瞻性队列中评估了减肥手术的10年结果,重点关注体重减轻和合并症的演变。方法:这是一项观察性研究,涉及96名在2013年至2024年间接受手术的患者。我们分析了超重减重的百分比(EWL %)和合并症缓解。78.1%的患者行胃旁路术(GB), 19.8%行垂直套管胃切除术(SG)。结果:2年时EWL最高为57.3%,10年时维持在43.3%。术前糖尿病和高血压是体重减轻的独立预测因素。在5年和10年的EWL %上,国药均显著优于国药(p < 0.05)。糖尿病、高血压、血脂异常、阻塞性睡眠呼吸暂停(OSA)和肝脂肪变性的缓解率较高,手术技术之间无显著差异。随访期间机械关节病无明显改善(48.9% vs 50.5%;P = 0.88)。结论:减肥手术在10年内保持了临床相关的体重减轻,长期来看,GB优于SG。合并症显著改善,除了关节病,尽管体重减轻,它仍然存在。
[Long-term effectiveness of bariatric surgery: weight and metabolic outcomes after 10 years of follow-up].
Introduction: we evaluated the 10-year outcomes of bariatric surgery in a prospective cohort, focusing on weight loss and the evolution of comorbidities.
Methods: this was an observational study involving 96 patients who underwent surgery between 2013 and 2024. We analyzed the percentage of excess weight loss (%EWL) and comorbidity remission. Of the patients, 78.1 % underwent gastric bypass (GB) and 19.8 % vertical sleeve gastrectomy (SG).
Results: the %EWL peaked at 57.3 % at 2 years and remained at 43.3 % at 10 years. Preoperative diabetes and hypertension were independent predictors of reduced weight loss. GB showed significant superiority over SG in %EWL at both 5 and 10 years (p < 0.05). Remission rates were high for diabetes, hypertension, dyslipidemia, obstructive sleep apnea (OSA), and hepatic steatosis, with no significant differences between surgical techniques. Mechanical arthropathy did not improve significantly during follow-up (48.9 % vs 50.5 %; p = 0.88).
Conclusions: bariatric surgery maintains clinically relevant weight loss at 10 years, with GB proving superior to SG in the long term. Comorbidities improve significantly, except for arthropathy, which persists despite weight loss.
期刊介绍:
The journal Nutrición Hospitalaria was born following the SENPE Bulletin (1981-1983) and the SENPE journal (1984-1985). It is the official organ of expression of the Spanish Society of Clinical Nutrition and Metabolism. Throughout its 36 years of existence has been adapting to the rhythms and demands set by the scientific community and the trends of the editorial processes, being its most recent milestone the achievement of Impact Factor (JCR) in 2009. Its content covers the fields of the sciences of nutrition, with special emphasis on nutritional support.